TNKS656 also proved a synergic effect with EGFR inhibitors in PC9, HCC827 and HCC4006 NSCLC cell lines through the inhibition of YAP signaling [113, 126, 127]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.